Form 4: CalciMedica Director Robert N. Wilson Acquires Additional Shares
SEC Form 4 Filing
Director Robert N. Wilson of CalciMedica, Inc. reports purchasing 8,443 shares of common stock at an average price of $3.234.
Summary
- On June 27, 2024, Robert N. Wilson, a director of CalciMedica, Inc., acquired 8,443 shares of common stock.
- The shares were purchased at an average price of $3.234, with prices ranging from $3.17 to $3.24.
- Following the transaction, Wilson directly owns 258,918 shares of CalciMedica common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of a director purchasing shares, which can be interpreted as a positive signal, but it's not overwhelmingly significant.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/27/2024 | Date of transaction: Robert N. Wilson purchased shares of common stock. |
| 07/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.